GlassScriptPhysician profile
Eric Andrew Pagan
NPI 1336596741
$36,890.79
in general payments reported to CMS, 2019-2025
10 companies · $1,432 in 2025
The $1,432 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $53.69 · 2021: $264 · 2022: $21K · 2023: $9,434 · 2024: $5,000 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $6,546 · Food and Beverage: $6,146 · Travel and Lodging: $2,719 · Education: $455.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $6,545.50 |
| Food and Beverage | $6,146.42 |
| Travel and Lodging | $2,718.94 |
| Education | $454.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,639.00 | 2021-2025 | Azure Xt Dr Mri Surescan, Micra, Cobalt Dr Mri Surescan |
| Abbott Laboratories | $5,885.58 | 2022-2024 | Aveir, Ensite Precision, Ensite |
| Biotronik INC. | $3,061.39 | 2023-2025 | Acticor 7 Vr-T Dx, Edora 8 Dr-T, Sentus |
| Boston Scientific Corporation | $2,723.47 | 2023-2025 | Lux-Dx Insertable Cardiac Monitor, Emblem Mri S-Icd, Farapulse |
| Astrazeneca Pharmaceuticals LP | $334.85 | 2020-2024 | |
| Cvrx, INC. | $104.63 | 2025 | Barostim Neo System |
| Cardiva Medical, INC. | $84.96 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amgen INC. | $21.58 | 2023 | Repatha |
| Philips North America LLC | $19.32 | 2022 | |
| Cordis US Corp. | $16.01 | 2025 | Mynx Control Venous |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Pagan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.